Literature DB >> 1458130

Tachycardia during cisapride treatment.

P P Humphrey, K T Bunce.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1458130      PMCID: PMC1884047          DOI: 10.1136/bmj.305.6860.1019-b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Tachycardia during cisapride treatment.

Authors:  S Olsson; I R Edwards
Journal:  BMJ       Date:  1992-09-26

Review 2.  The 5-HT4 receptor: a place in the sun.

Authors:  J Bockaert; J R Fozard; A Dumuis; D E Clarke
Journal:  Trends Pharmacol Sci       Date:  1992-04       Impact factor: 14.819

3.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

4.  The action of cisapride on gastric emptying and the pharmacodynamics and pharmacokinetics of oral diazepam.

Authors:  D N Bateman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  4 in total
  4 in total

1.  Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance.

Authors:  Michael Perrio; Simon Voss; Saad A W Shakir
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 2.  Drug interactions with cisapride: clinical implications.

Authors:  E L Michalets; C R Williams
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

Review 3.  A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.

Authors:  J Tack; G Coremans; J Janssens
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

Review 4.  Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.